TARGET AREAS OF MAJOR ANTIBIOTICS AND SYNTHETIC AGENTS The microbial cell wall Protein synthesis Chromosome function and replication Folate antagonists The cytoplasmic membrane PEPTIDOGLYCAN Composed of sugar (glycan) chains cross - linked by short peptide chains Contain alternating units of N - acetylmuramic acid and N – acetylglucosamine Each N-acetylmuramic acid contains short peptide substituent made up of four amino acids (stem peptides) Key feature contains D-isomer (D-alanine and D-glutamic acid) in stem peptides and meso-diaminopimelic acid VITAL ROLE OF PEPTIDOGLYCAN Responsible for maintenance of cell shape Gives mechanical strength of the bacterial cell If damaged: 1. Bacterial cell becomes distorted 2. Cells swell and lyse resulting from high osmotic pressure Interferes with the early stage of synthesis of peptidoglycan involving the assembly of the dipeptide d-alanyl - d-alanine Inhibits racemase and ligase activity by mimicking and binding to pyridoxal phosphate (cofactor of enzymes) Also blocks the coupling of dipeptide to three other amino acids forming he stem peptide on UDP-N-acetylmuramic acid The glycopeptides vancomycin and teicoplanin act at the stage where the peptidoglycan precursors are inserted into the cell wall by the transglycosylase enzyme on the outer face of the cell membrane Glycopeptides block this processes of transglycosylase by binding to the disaccharide peptidoglycan precursor, specifically to the d-alanyl - d-alanine Resistance develop results from alteration in D-alanyl-D-alanine substrate to D-alanyl-Dlactacte (seen in VRE) Glycopeptides must cross the cell wall to reach outer face of cell membrane where transglycosylation takes place. However, they are too large to penetrate the outer membrane of gram-negative bacteria The β - lactam antibiotics inhibit transpeptidases by acting as alternative substrates for the enzyme The vital cross - linking of the peptidoglycan is therefore blocked but other aspect of cell growth occurs Also activates autolysins on cell wall Use in combination with susceptible β – lactams protecting them from inactivation by the β – lactamases Inhibitors are hydrolysed by the β - lactamases in the same manner as susceptible β – lactam antibiotics. But instead of rapid release from active site, it remains bound and undergo one of several fates Ex. It interact with second enzyme residue with active site of Blactamase forming irreversibly inhibited complex MYCOLIC ACID COMPONENTS 1. Arabinogalactan polysaccharide 2. Peptidoglycan 3. High-molecular weight lipids a. mycolic acids b. glycolipids c. phospholipids d. waxes Isoniazid interferes with mycolic acid synthesis by inhibiting an enoyl reductase (InhA) It is converted inside the mycobacteria to a free radical species by a catalase peroxidase enzyme, KatG. The active free radicals then attack and inhibit the enoyl reductase, InhA Ethambutol blocks assembly of the arabinogalactan polysaccharide by inhibition of an arabinotransferase enzyme They interfere with the synthesis of the β-1,3-d-glucan Without the glucan polymer, the integrity of the fungal cell wall is compromised, yeast cells lose their rigidity and become like protoplasts Effect is pronounced in Candida and Aspergillus species The process of protein synthesis involves the ribosome, mRNA, a series of amino - acyltransfer RNA (tRNA) molecules and accessory protein factors involved in initiation, elongation and termination Bacterial ribosomes are smaller than their mammalian counterparts. They consist of one 30S and one 50S subunit Most of the information on the mechanisms of action of aminoglycoside – aminocyclitol (AGAC) antibiotics comes from studies with streptomycin To interfere with the initiation and assembly of the bacterial ribosome Streptomycin binds tightly to one of the protein components of the 30S subunit which prevents initiation and assembly of the ribosome 1. 2. Streptomycin exerts two effects: inhibition of protein synthesis by freezing the initiation complex misreading of the codons through distortion of the 30S subunit Binding of just one molecule of tetracycline to the bacterial 30S subunit The effect is to block the binding of aminoacyl - tRNA to the A site of the ribosome and halt protein synthesis Tetracyclines are bacteriostatic rather than bactericidal Resistance to the tetracyclines occurs through failure of the active uptake system or the action of active efflux pumps, which remove the drug from the cells before it can interfere with ribosome function Of the four possible optical isomers of chloramphenicol, only Dthreo form is active This antibiotic selectively inhibits protein synthesis in bacterial ribosomes by binding to the 50S subunit Chloramphenicol has a broad spectrum of activity, which covers Gram - positive and Gram - negative bacteria, mycoplasmas, rickettsia and chlamydia Has valuable property of penetrating into mammalian cells and is therefore the drug of choice for treatment of intracellular pathogens Erythromycin is a member of the macrolide group of antibiotics It selectively inhibits protein synthesis in a broad range of bacteria by binding to the 50S subunit and blocks translocation By blocking the translocation process, erythromycin causes release of incomplete polypeptides from the ribosome The azalides has same mechanism of actions with macrolides but have improved intracellular penetration over the macrolides This agent binds selectively to a region of the 50S ribosomal subunit close to that of chloramphenicol and erythromycin. It blocks elongation of the peptide chain by inhibition of peptidyl transferase Have been used in combination (in a 30 : 70 ratio) to treat infections caused by staphylococci and enterococci, particularly methicillin - resistant Staph. aureus (MRSA) and VRE. Their action is synergistic The main target is the bacterial 50S ribosome: dalfopristin alters the shape of the ribosome so that more quinupristin can bind Oxazolidinones such as linezolid act at the early stage of protein synthesis, preventing the formation of the initiation complex between the 30S subunit, mRNA and fmet – tRNA The target of mupirocin is one of a group of enzymes which couple amino acids to their respective tRNAs for delivery to the ribosome and incorporation into protein The particular enzyme inhibited by mupirocin is involved in producing isoleucyl – tRNA This steroidal antibiotic does not act on the ribosome itself, but on one of the associated elongation factors, EF – G Binds with EF-G:GDP complex to the ribosome after one round of translocation has taken place These agents bind to the component of the 50S bacterial ribosome and block peptide bond formation by interfering with the binding of the peptidyl transferase region with the aminoacyl - tRNA substrates in the A and P sites on the ribosome During replication the circular double helix must be unwound to allow the DNA polymerase enzymes to synthesize new complementary strands In a bacterium such as E. coli four different topoisomerase enzymes are responsible for maintaining the shape of DNA during cell division They act by cutting one or both of the DNA strands; they remove and generate supercoiling, then reseal the strands The fluoroquinolones selectively inhibit topoisomerases II and IV These agents also cause DNA strand breakage, but by a direct chemical action rather than by inhibition of a topoisomerase The nitro group of metronidazole is converted to a nitronate radical by the low redox potential within cells. The pyruvate:ferredoxin oxidoreductase (POR) is a major metabolic pathway in anaerobic bacteria and protozoa used for generation of ATP. This system converts metronidazole to its active form which then attacks the DNA, producing strand breakage Binding of just one molecule of rifampicin inhibits the initiation stage of transcription The action of rifampicin is specific for the microbial RNA polymerase Rifabutin, which has enhanced activity against Mycobacterium avium complex, is thought to act in the same way as rifampicin This antifungal agent inhibits DNA synthesis at the early stages involving production of the nucleotide thymidylic acid (TMP) An important antifungal agent in the treatment of life threatening infections Resistance can occur due to active efflux of the drug from the cells before it can inhibit DNA synthesis Bacterial and protozoal cells must synthesize dihydrofolic acid (DHF) from pteridine, p - aminobenzoic acid (PABA) and glutamate. DHF is converted to tetrahydrofolic acid (THF) by the enzyme dihydrofolate reductase (DHFR). THF supplies single carbon units for various pathways including DNA, RNA and methionine synthesis Sulphonamides - they competitively inhibit the incorporation of PABA Trimethoprim - selective inhibitor of bacterial DHFR Pyrimethamine - selective inhibitor of plasmodial DHFR Polymyxin E (colistin) is used in the treatment of serious Gram - negative bacterial infections It binds tightly to the lipid A component of LPS in the outer membrane of Gram - negative bacteria Permeability barrier is destroyed The polymyxin molecules can then penetrate to the cytoplasmic membrane where they bind to phospholipids, disrupt membrane integrity, and cause irreversible leakage of cytoplasmic components The compound inserts itself into the cytoplasmic membrane and drug molecules aggregate together forming channels The leakage of potassium ions from the cells results in inhibition of macromolecular synthesis and cell death Amphotericin B and nystatin are the most commonly used members of this group of antifungal agents Derive their action from their strong affinity towards sterols, particularly ergosterol Polyene is pulled into the membrane interior, destabilizing the structure and causing leakage of cytoplasmic constituents The azole antifungal drugs act by inhibiting the synthesis of the sterol components of the fungal membrane Cause rapid defects in fungal membrane integrity due to reduced levels of ergosterol Inhibits the enzyme squalene epoxidase at an early stage in fungal sterol biosynthesis Innate resistance Phenotypic - resulting from adaptation to growth within a specific environment Conjugation Mutations Inactivation of the drug Alteration of the target Reduced cellular uptake Increased efflux
© Copyright 2026 Paperzz